Form D · Biotechnology
NTXBIO, LLC
Santa Fe, NM · CIK 0001656009
Offering snapshot reported May 13, 2019 · SEC filing
- Reported sold
- $915K Offering amount: $2.5M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 30, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 13, 2019 | Initial | $915,000 | No comparison | 11 | SEC filing |
| Aug 15, 2018 | Amendment | $522,361 | $150,000vs Dec 6, 2017 | 8 | SEC filing |
| Dec 6, 2017 | Initial | $372,361 | No comparison | 7 | SEC filing |
| Oct 27, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-339429
Source: Form D, filed May 13, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Ennis | Executive |
| Michelle Miller | Executive |
| Stuart Schoenmann | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6401 Richards Ave.
Santa Fe, NM, 87508
Santa Fe, NM, 87508